drugset / Trial / NCT01614184
Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study goal is to develop a new method of intraoperative lymphatic mapping with fluorescent contrast agents to improve the outcome of therapeutic breast cancer surgery.
Timeline
- Start
- 2008-05
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluorescein | Diagnostic / imaging agent | 0.25 ml | Other |